✦ LIBER ✦

Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors

✍ Scribed by Emilia Prakoso; Simone I. Strasser; David J. Koorey; Deborah Verran; Geoffrey W. McCaughan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prevention of hepatitis B virus infectio

✍ Taketoshi Suehiro; Mitsuo Shimada; Keiji Kishikawa; Tatsuo Shimura; Yuji Soejima 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Case Report of Lamivudine-Resistant Hepa

✍ R. D. Yen; H. Bonatti; J. Mendez; J. Aranda-Michel; R. Satyanarayana; R. C. Dick 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Prevention of de novo hepatitis B with a

✍ Matthew S. Chang; Sonja K. Olsen; Elsa M. Pichardo; Scott Heese; Jessica B. Stil 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

Safety of using hepatitis B virus core a

✍ Enver Akalin; Scott Ames; Vinita Sehgal; Barbara Murphy; Jonathan S Bromberg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB